Stock Analysis

Cryoport Insiders Miss 28% Gain After Offloading Stock

NasdaqCM:CYRX
Source: Shutterstock

Even though Cryoport, Inc. (NASDAQ:CYRX) stock gained 28% last week, insiders who sold US$295k worth of stock over the past year are probably better off. Holding on to stock would have meant their investment would be worth less now than it was at the time of sale. Thus selling at an average price of US$9.23, which is higher than the current price, may have been the best decision.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.

Our free stock report includes 3 warning signs investors should be aware of before investing in Cryoport. Read for free now.
Advertisement

The Last 12 Months Of Insider Transactions At Cryoport

Over the last year, we can see that the biggest insider sale was by the insider, Richard Jay Berman, for US$109k worth of shares, at about US$13.41 per share. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. The good news is that this large sale was at well above current price of US$6.98. So it is hard to draw any strong conclusion from it.

Cryoport insiders didn't buy any shares over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

Check out our latest analysis for Cryoport

insider-trading-volume
NasdaqCM:CYRX Insider Trading Volume May 9th 2025

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).

Insiders At Cryoport Have Sold Stock Recently

Over the last three months, we've seen significant insider selling at Cryoport. In total, insiders dumped US$97k worth of shares in that time, and we didn't record any purchases whatsoever. This may suggest that some insiders think that the shares are not cheap.

Does Cryoport Boast High Insider Ownership?

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. We usually like to see fairly high levels of insider ownership. From our data, it seems that Cryoport insiders own 2.9% of the company, worth about US$8.2m. Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!

So What Do The Cryoport Insider Transactions Indicate?

Insiders sold Cryoport shares recently, but they didn't buy any. Looking to the last twelve months, our data doesn't show any insider buying. When you combine this with the relatively low insider ownership, we are very cautious about the stock. We'd certainly practice some caution before buying! So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. To that end, you should learn about the 3 warning signs we've spotted with Cryoport (including 1 which shouldn't be ignored).

Of course Cryoport may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.